PATTERN OF DRUG UTILIZATION DURING PREGNANCY AT A TEACHING HOSPITAL – A PROSPECTIVE OBSERVATIONAL STUDY

MANASA MR; SWETHA K

doi:10.22159/ajpcr.2024v17i9.51745

Authors

MANASA MR Department of Pharmacology, Karwar Institute of Medical Sciences, Karwar, Karnataka, India
SWETHA K Department of Pharmacology, Karwar Institute of Medical Sciences, Karwar, Karnataka, India. https://orcid.org/0000-0003-2124-359X

DOI:

https://doi.org/10.22159/ajpcr.2024v17i9.51745

Keywords:

Pregnancy, US Food and Drug Administration, Drug utilization, the World Health Organization core indicators

Abstract

Objectives: The objective of the study is (1) to assess the drug utilization pattern in pregnancy and (2) to assist in ensuring rational drug therapy.

Methods: A prospective, cross-sectional observational study was conducted at the Obstetrics and Gynecology Outpatient Department of KRIMS, Karwar. 546 pregnant women aged 18–40 years were included. Data collected from prescriptions were analyzed for adherence to the World Health Organization core prescribing indicators and classified as per the US Food and Drug Administration (FDA) pregnancy categories.

Results: The average age of study participants was 26.96 years with an urban preponderance (77.65%). Morning sickness (35.71%) and upper respiratory tract infections (20.7%) were the most frequent ailments encountered. 6383 drugs were prescribed in 2555 prescriptions with an average of 2.5 drugs per prescription. Iron and calcium supplements (28.75% each) were the most common drugs prescribed. 12.25% of prescriptions had fixed-dose combinations. 86.28% of drugs were from the National List of Essential Medicine (NLEM) and the majority of drugs belonged to FDA pregnancy category B (39.02%).

Conclusion: Rational prescribing was demonstrated in our study by a fewer number of drugs per prescription and lesser utilization of antibiotics and injections. Generic names were commonly used and drugs were selected from NLEM. It is essential to prescribe medicines with established efficacy and safety to ensure maternal and fetal well-being.

Downloads

Download data is not yet available.

References

Sachdeva P, Patel BG, Patel BK. Drug use in pregnancy; a point to ponder!. Indian J Pharm Sci. 2009 Feb;71(1):1-7. doi: 10.4103/0250- 474X.51941, PMID: 20177448

Abubakar K, Abdulkadir R, Abubakar SB, Jimoh AO, Ugwah- Oguejiofor JC, Danzaki AM. Drug utilization pattern in pregnancy in a Tertiary Hospital in Sokoto, North West. J Health Sci. 2014;4(4):99-104. doi: 10.5923/j.health.20140404.04

Selvaraj N, Sekar A, Gandhi R, Jayabalan N, Ganesan S, Raja Mohammad MA. Drug utilization pattern in pregnancy at a tertiary care hospital in Puducherry: A cross sectional observational study. Int J Basic Clin Pharmacol. 2018 May;7(5):900-5. doi: 10.18203/2319- 2003.ijbcp20181632

Blot I, Papiernik E, Kaltwasser JP, Werner E, Tchernia G. Influence of routine administration of folic acid and iron during pregnancy. Gynecol Obstet Invest. 1981 Mar 16;12(6):294-304. doi:10.1159/000299659, PMID: 7297938

Sharma R, Kapoor B, Verma U. Drug utilization pattern during pregnancy in North India. Indian J Med Sci. 2006 Jul;60(7):277-87. doi: 10.4103/0019-5359.26602, PMID: 16864912

World Health Organization. Introduction to Drug Utilization Research; 2003c. Available from: https://www.who.int/publications-detail- redirect/8280820396 [Last accessed on 2024 Mar 30].

Sharma N, Jhanwar A. Study of drug utilization pattern in gynecology department of tertiary care hospital of Rajasthan, India. Int J Reprod Contracept Obstet Gynecol. 2018 Jul;7(7):2650-4. doi: 10.18203/2320- 1770.ijrcog20182466

Chaudhari A, Aasani D, Trivedi H. Drug utilization study in antenatal clinic of obstetrics gynaecology department of a tertiary care hospital attached with Medical College. Indian J Pharm Pharmacol. 2016 Oct;3(4):186-91. doi: 10.18231/2393-9087.2016.0012

Gujar A, Gulecha DV, Zalte DA. Drug utilization studies using WHO prescribing indicators from India: A systematic review. Health Policy Technol. 2021 Jul 6;10(3):100547. doi: 10.1016/j.hlpt.2021.100547

Savitha A, Saritha H, Gumma K. Drug pattern use during pregnancy: A prospective study at tertiary care teaching hospital. Int J Basic Clin Pharmacol. 2016 Jan;5(1):192-5. doi: 10.18203/2319-2003. ijbcp20160126

Rajan B, Pasangha E, Devi P, George S. Patterns of medication use and their determinants in pregnancy among women admitted to the obstetrics wards of a tertiary care hospital: A cross-sectional study: Patterns of medication use and their determinants in pregnancy. J Pharmacol Pharmacother. 2023 Jan 19;13(4):388-95. doi: 10.1177/0976500X221147803

Patel K, Joshi H, Patel V. A study of morbidity and drug utilization pattern in indoor patients of high risk pregnancy at tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2013 Sep;2(3):372-8. doi: 10.5455/2320-1770.ijrcog20130922

Talin IA, Abid MH, Samad MA, Domínguez Azpíroz I, De la Torre Diez I, Ashraf I, et al. Exploring factors influencing the severity of pregnancy anemia in India: A study using proportional odds model. Sci Rep. 2023;13:22816. doi: 10.1038/s41598-023-49872-x, PMID: 38129518

Ellilaä P, Laitinen L, Nurmi M, Rautava P, Koivisto M, Polo-Kantola P. Nausea and vomiting of pregnancy: A study with pregnancy-unique quantification of emesis questionnaire. Eur J Obstet Gynecol Reprod Biol. 2018 Nov;230:60-7. doi: 10.1016/j.ejogrb.2018.09.031, PMID: 30243227

Tosto V, Tsibizova V, Di Renzo GC. In: Di Renzo GC, editor. The Continuous Textbook of Women’s Medicine Series-Obstetrics Module. Vol. 6; 2021. Available from: https://lowm.com/article/heading/vol- 6--pregnancy-complaints-and-complications-clinical-presentations- -nausea-and-vomiting-in-pregnancy/id/415723 [Last accessed on 2024 Jun 02].

Bustos M, Venkataramanan R, Caritis S. Nausea and vomiting of pregnancy-what’s new? Auton Neurosci. 2017 Jan;202:62-72. doi: 10.1016/j.autneu.2016.05.002, PMID: 27209471

Siminerio LL, Bodnar LM, Venkataramanan R, Caritis SN. Ondansetron use in pregnancy. Obstet Gynecol. 2016 May;127(5):873-7. doi: 10.1097/AOG.0000000000001375, PMID: 27054931

Kerure RD, Biradar AV, Lakshetty S, Biradar S. A study of urinary tract infection in pregnancy and its effect on maternal and perinatal outcome. Int J Reprod Contracept Obstet Gynecol. 2024 Feb;13(2):284-9. doi: 10.18203/2320-1770.ijrcog20240031

World Health Organiszation. How to Investigate Drug use in Health Facilities: Selected Drug Use Indicators; 1993c. Available from: https:// www.who.int/publications-detail-redirect/who-dap-93.1 [Last accessed on 2024 Apr 01].

World Health Organization. WHO Model List of Essential Medicines- 23rd List; 2023. p. c2023. Available from: https://www.who.int/ publications/i/item/who-mhp-hps-eml-2023.02 [Last accessed on 2024 Jun 03].